Depressão em crianças

Referências

Principais artigos

Zuckerbrot RA, Cheung A, Jensen PS, et al. Guidelines for adolescent depression in primary care (GLAD-PC): Part I. Practice preparation, identification, assessment, and initial management. Pediatrics. 2018 Mar;141(3):e20174081.Texto completo  Resumo

Birmaher B, Brent D, AACAP Work Group on Quality Issues, et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007 Nov;46(11):1503-26. Resumo

Cheung AH, Zuckerbrot RA, Jensen PS, et al. Guidelines for adolescent depression in primary care (GLAD-PC): Part II. Treatment and ongoing management. Pediatrics. 2018 Mar;141(3):e20174082.Texto completo  Resumo

National Institute for Health and Care Excellence. Depression in children and young people: identification and management. Jun 2019 [internet publication].Texto completo

Locher C, Koechlin H, Zion SR, et al. Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis. JAMA Psychiatry. 2017 Oct 1;74(10):1011-20.Texto completo  Resumo

Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008 Feb 27;299(8):901-13.Texto completo  Resumo

Artigos de referência

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., (DSM-5). Washington, DC: American Psychiatric Publishing; 2013.

2. World Health Organization. ICD-11 for mortality and morbidity statistics (ICD-11 MMS). Feb 2022 [internet publication].Texto completo

3. Ghandour RM, Sherman LJ, Vladutiu CJ, et al. Prevalence and treatment of depression, anxiety, and conduct problems in US children. J Pediatr. 2019 Mar;206:256-67.Texto completo  Resumo

4. Avenevoli S, Swendsen J, He JP, et al. Major depression in the national comorbidity survey-adolescent supplement: prevalence, correlates, and treatment. J Am Acad Child Adolesc Psychiatry. 2015 Jan;54(1):37-44.Texto completo  Resumo

5. Albert PR. Why is depression more prevalent in women? J Psychiatry Neurosci. 2015 Jul;40(4):219-21.Texto completo  Resumo

6. Hankin BL, Young JF, Abela JR, et al. Depression from childhood into late adolescence: influence of gender, development, genetic susceptibility, and peer stress. J Abnorm Psychol. 2015 Nov;124(4):803-16.Texto completo  Resumo

7. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):593-602.Texto completo  Resumo

8. Lawrence D, Hafekost J, Johnson SE, et al. Key findings from the second Australian child and adolescent survey of mental health and wellbeing. Aust N Z J Psychiatry. 2016 Sep;50(9):876-86.Texto completo  Resumo

9. Jack RH, Hollis C, Coupland C, et al. Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: a population-based cohort study. PLoS Med. 2020 Jul 22;17(7):e1003215.Texto completo  Resumo

10. Wijlaars LP, Nazareth I, Petersen I. Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN). PLoS One. 2012;7(3):e33181.Texto completo  Resumo

11. Pumariega AJ, Roth EM, Rogers KM. Depression in immigrant and minority children and youth. In: Rey JM, Birmaher B, eds. Treating child and adolescent depression. Baltimore, MD: Lippincott Williams & Wilkins; 2009:321-31.

12. Pinquart M, Shen Y. Depressive symptoms in children and adolescents with chronic physical illness: an updated meta-analysis. J Pediatr Psychol. 2011 May;36(4):375-84.Texto completo  Resumo

13. Beardslee WR, Gladstone TR, O'Connor EE. Transmission and prevention of mood disorders among children of affectively ill parents: a review. J Am Acad Child Adolesc Psychiatry. 2011 Nov;50(11):1098-109. Resumo

14. Thapar A, Collishaw S, Pine DS, et al. Depression in adolescence. Lancet. 2012 Mar 17;379(9820):1056-67.Texto completo  Resumo

15. Harkness KL, Alavi N, Monroe SM, et al. Gender differences in life events prior to onset of major depressive disorder: the moderating effect of age. J Abnorm Psychol. 2010 Nov;119(4):791-803.Texto completo  Resumo

16. Keenan K, Hipwell A, Babinski D, et al. Examining the developmental interface of cortisol and depression symptoms in young adolescent girls. Psychoneuroendocrinology. 2013 Oct;38(10):2291-9.Texto completo  Resumo

17. Owens M, Herbert J, Jones PB, et al. Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms. Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3638-43.Texto completo  Resumo

18. Ruttle PL, Shirtcliff EA, Serbin LA, et al. Disentangling psychobiological mechanisms underlying internalizing and externalizing behaviors in youth: longitudinal and concurrent associations with cortisol. Horm Behav. 2011 Jan;59(1):123-32.Texto completo  Resumo

19. Ryan ND, Birmaher B, Perel JM, et al. Neuroendocrine response to L-5-hydroxytryptophan challenge in prepubertal major depression: depressed vs normal children. Arch Gen Psychiatry. 1992 Nov;49(11):843-51. Resumo

20. Byrum CE, Ahearn EP, Krishnan KR. A neuroanatomic model for depression. Prog Neuropsychopharmacol Biol Psychiatry. 1999 Feb;23(2):175-93. Resumo

21. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci. 1997 Summer;9(3):471-81. Resumo

22. Emslie GJ, Rush AJ, Weinberg WA, et al. Children with major depression show reduced rapid eye movement latencies. Arch Gen Psychiatry. 1990 Feb;47(2):119-24. Resumo

23. Emslie GJ, Rush AJ, Weinberg WA, et al. Sleep EEG features of adolescents with major depression. Biol Psychiatry. 1994 Nov 1;36(9):573-81. Resumo

24. Lahmeyer HW, Poznanski EO, Bellur SN. EEG sleep in depressed adolescents. Am J Psychiatry. 1983 Sep;140(9):1150-3. Resumo

25. Dahl RE, Puig-Antich J, Ryan ND, et al. EEG sleep in adolescents with major depression: the role of suicidality and inpatient status. J Affect Disord. 1990 May;19(1):63-75. Resumo

26. Rao U, Hammen CL, Poland RE. Risk markers for depression in adolescents: sleep and HPA measures. Neuropsychopharmacology. 2009 Jul;34(8):1936-45.Texto completo  Resumo

27. Armitage R, Hoffmann R, Emslie G, et al. Sleep microarchitecture in childhood and adolescent depression: temporal coherence. Clin EEG Neurosci. 2006 Jan;37(1):1-9. Resumo

28. Puig-Antich J, Goetz R, Hanlon C, et al. Sleep architecture and REM sleep measures in prepubertal children with major depression: a controlled study. Arch Gen Psychiatry. 1982 Aug;39(8):932-9. Resumo

29. Goetz RR, Puig-Antich J, Ryan N, et al. Electroencephalographic sleep of adolescents with major depression and normal controls. Arch Gen Psychiatry. 1987 Jan;44(1):61-8. Resumo

30. Forbes EE, Dahl RE. Neural systems of positive affect: relevance to understanding child and adolescent depression? Dev Psychopathol. 2005 Summer;17(3):827-50.Texto completo  Resumo

31. Maeng S, Zarate CA Jr. The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep. 2007 Dec;9(6):467-74. Resumo

32. Beesdo K, Lau JY, Guyer AE, et al. Common and distinct amygdala-function perturbations in depressed vs anxious adolescents. Arch Gen Psychiatry. 2009 Mar;66(3):275-85. Resumo

33. Forbes EE, Christopher May J, Siegle GJ, et al. Reward-related decision-making in pediatric major depressive disorder: an fMRI study. J Child Psychol Psychiatry. 2006 Oct;47(10):1031-40.Texto completo  Resumo

34. Steingard RJ, Yurgelun-Todd DA, Hennen J, et al. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biol Psychiatry. 2000 Dec 1;48(11):1053-61. Resumo

35. Rosenberg DR, Mirza Y, Russell A, et al. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry. 2004 Sep;43(9):1146-53. Resumo

36. Weissman MM, Wickramaratne P, Nomura Y, et al. Families at high and low risk for depression: a 3-generation study. Arch Gen Psychiatry. 2005 Jan;62(1):29-36.Texto completo  Resumo

37. Kendler KS, Gatz M, Gardner CO, et al. Age at onset and familial risk for major depression in a Swedish national twin sample. Psychol Med. 2005 Nov;35(11):1573-9. Resumo

38. Weissman MM, Warner V, Wickramaratne P, et al. Offspring of depressed parents: 10 years later. Arch Gen Psychiatry. 1997 Oct;54(10):932-40. Resumo

39. Ramchandani P, Stein A, Evans J, et al. Paternal depression in the postnatal period and child development: a prospective population study. Lancet. 2005 Jun 25-Jul 1;365(9478):2201-5. Resumo

40. Weissman MM, Wickramaratne P, Nomura Y, et al. Offspring of depressed parents: 20 years later. Am J Psychiatry. 2006 Jun;163(6):1001-8. Resumo

41. Lewis G, Neary M, Polek E, et al. The association between paternal and adolescent depressive symptoms: evidence from two population-based cohorts. Lancet Psychiatry. 2017 Dec;4(12):920-6.Texto completo  Resumo

42. McLeod BD, Weisz JR, Wood JJ. Examining the association between parenting and childhood depression: a meta-analysis. Clin Psychol Rev. 2007 Dec;27(8):986-1003. Resumo

43. Pilowsky DJ, Wickramaratne P, Nomura Y, et al. Family discord, parental depression, and psychopathology in offspring: 20-year follow-up. J Am Acad Child Adolesc Psychiatry. 2006 Apr;45(4):452-60. Resumo

44. Buu A, Dipiazza C, Wang J, et al. Parent, family, and neighborhood effects on the development of child substance use and other psychopathology from preschool to the start of adulthood. J Stud Alcohol Drugs. 2009 Jul;70(4):489-98. Resumo

45. Puig-Antich J, Goetz D, Davies M, et al. A controlled family history study of prepubertal major depressive disorder. Arch Gen Psychiatry. 1989 May;46(5):406-18. Resumo

46. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003 Jul 18;301(5631):386-9. Resumo

47. American Academy of Pediatrics Committee On Adolescence. Office-based care for lesbian, gay, bisexual, transgender, and questioning youth. Pediatrics. 2013 Jul;132(1):198-203.Texto completo  Resumo

48. Burton CM, Marshal MP, Chisolm DJ, et al. Sexual minority-related victimization as a mediator of mental health disparities in sexual minority youth: a longitudinal analysis. J Youth Adolesc. 2013 Mar;42(3):394-402.Texto completo  Resumo

49. McLaughlin KA, Hatzenbuehler ML, Xuan Z, et al. Disproportionate exposure to early-life adversity and sexual orientation disparities in psychiatric morbidity. Child Abuse Negl. 2012 Sep;36(9):645-55.Texto completo  Resumo

50. Stewart SM, Rao U, White P. Depression and diabetes in children and adolescents. Curr Opin Pediatr. 2005 Oct;17(5):626-31. Resumo

51. Goodwin RD, Messineo K, Bregante A, et al. Prevalence of probable mental disorders among pediatric asthma patients in an inner-city clinic. J Asthma. 2005 Oct;42(8):643-7. Resumo

52. Ballard CG, Davis R, Cullen PC, et al. Prevalence of postnatal psychiatric morbidity in mothers and fathers. Br J Psychiatry. 1994 Jun;164(6):782-8. Resumo

53. Xie RH, He G, Koszycki D, et al. Prenatal social support, postnatal social support, and postpartum depression. Ann Epidemiol. 2009 Sep;19(9):637-43. Resumo

54. Deal LW, Holt VL. Young maternal age and depressive symptoms: results from the 1988 National Maternal and Infant Health Survey. Am J Public Health. 1998 Feb;88(2):266-70.Texto completo  Resumo

55. Barnett B, Morgan M. Postpartum psychiatric disorder: who should be admitted and to which hospital? Aust N Z J Psychiatry. 1996 Dec;30(6):709-14. Resumo

56. Fitzpatrick KM, Piko BF, Wright DR, et al. Depressive symptomatology, exposure to violence, and the role of social capital among African American adolescents. Am J Orthopsychiatry. 2005 Apr;75(2):262-74. Resumo

57. Fergusson DM, Boden JM, Horwood LJ. Tests of causal links between alcohol abuse or dependence and major depression. Arch Gen Psychiatry. 2009 Mar;66(3):260-6. Resumo

58. Rao U. Links between depression and substance abuse in adolescents: neurobiological mechanisms. Am J Prev Med. 2006 Dec;31(6 suppl 1):S161-74. Resumo

59. Hetrick SE, Cox GR, Witt KG, et al. Cognitive behavioural therapy (CBT), third-wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents. Cochrane Database Syst Rev. 2016 Aug 9;(8):CD003380.Texto completo  Resumo

60. Christensen H, Pallister E, Smale S, et al. Community-based prevention programs for anxiety and depression in youth: a systematic review. J Prim Prev. 2010 Jun;31(3):139-70. Resumo

61. Calear AL, Christensen H. Review of internet-based prevention and treatment programs for anxiety and depression in children and adolescents. Med J Aust. 2010 Jun 7;192(11 suppl):S12-4. Resumo

62. Whittaker R, Merry S, Stasiak K, et al. MEMO - a mobile phone depression prevention intervention for adolescents: development process and postprogram findings on acceptability from a randomized controlled trial. J Med Internet Res. 2012 Jan 24;14(1):e13. Resumo

63. Zuckerbrot RA, Cheung A, Jensen PS, et al. Guidelines for adolescent depression in primary care (GLAD-PC): Part I. Practice preparation, identification, assessment, and initial management. Pediatrics. 2018 Mar;141(3):e20174081.Texto completo  Resumo

64. Pinhas-Hamiel O, Doron-Panush N, Reichman B, et al. Obese children and adolescents: a risk group for low vitamin B12 concentration. Arch Pediatr Adolesc Med. 2006 Sep;160(9):933-6.Texto completo  Resumo

65. Siu AL; US Preventive Services Task Force. Screening for depression in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016 Mar 1;164(5):360-6.Texto completo  Resumo

66. Asarnow JR, Rozenman M, Wiblin J, et al. Integrated medical-behavioral care compared with usual primary care for child and adolescent behavioral health: a meta-analysis. JAMA Pediatr. 2015 Oct;169(10):929-37.Texto completo  Resumo

67. Reynolds WM. Reynolds adolescent depression scale. Odessa, FL: Psychological Assessment Resources; 1987.

68. Reynolds WM. Reynolds child depression scale. Odessa, FL: Psychological Assessment Resources; 1987.

69. Myers K, Winters NC. Ten-year review of rating scales. I: Overview of scale functioning, psychometric properties, and selection. J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2):114-22. Resumo

70. Angold A, Costello EJ, Messer SC, et al. The development of a short questionnaire for use in epidemiological studies of depression in children and adolescents. Int J Meth Psychiatr Res. 1995;5:237-49.

71. Messer SC, Angold A, Loeber R, et al. The development of a short questionnaire for use in epidemiological studies of depression in children and adolescents: factor composition and structure across development. Int J Meth Psychiatr Res. 1995;5:251-62.

72. Katon W, Russo J, Richardson L, et al. Anxiety and depression screening for youth in a primary care population. Ambul Pediatr. 2008 May-Jun;8(3):182-8.Texto completo  Resumo

73. Beck AT, Steer RA. Beck Depression Inventory (BDI) Manual. 2nd ed. San Antonio, TX: Psychological Corporation; 1993.

74. Kovacs, M. Children’s depression inventory. North Tonawanda, NY: Multi-Health Systems, Inc; 1992.

75. Richardson LP, McCauley E, Grossman DC, et al. Evaluation of the Patient Health Questionnaire-9 Item for detecting major depression among adolescents. Pediatrics. 2010 Dec;126(6):1117-23.Texto completo  Resumo

76. Birmaher B, Brent D, AACAP Work Group on Quality Issues, et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007 Nov;46(11):1503-26. Resumo

77. Cheung AH, Zuckerbrot RA, Jensen PS, et al. Guidelines for adolescent depression in primary care (GLAD-PC): Part II. Treatment and ongoing management. Pediatrics. 2018 Mar;141(3):e20174082.Texto completo  Resumo

78. Hughes CW, Emslie GJ, Crismon ML, et al. Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry. 2007 Jun;46(6):667-86. Resumo

79. National Institute for Health and Care Excellence. Depression in children and young people: identification and management. Jun 2019 [internet publication].Texto completo

80. Emslie GJ, Kennard BD, Mayes TL, et al. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry. 2008 Apr;165(4):459-67.Texto completo  Resumo

81. Kroll L, Harrington R, Jayson D, et al. Pilot study of continuation cognitive-behavioral therapy for major depression in adolescent psychiatric patients. J Am Acad Child Adolesc Psychiatry. 1996 Sep;35(9):1156-61. Resumo

82. Cheung A, Kusumakar V, Kutcher S, et al. Maintenance study for adolescent depression. J Child Adolesc Psychopharmacol. 2008 Aug;18(4):389-94. Resumo

83. Blumenthal JA, Babyak MA, Doraiswamy PM, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007 Sep-Oct;69(7):587-96.Texto completo  Resumo

84. Strohle A, Hofler M, Pfister H, et al. Physical activity and prevalence and incidence of mental disorders in adolescents and young adults. Psychol Med. 2007 Nov;37(11):1657-66. Resumo

85. Axelsdóttir B, Biedilae S, Sagatun Å, et al. Review: exercise for depression in children and adolescents - a systematic review and meta-analysis. Child Adolesc Ment Health. 2021 Nov;26(4):347-56. Resumo

86. Oberste M, Medele M, Javelle F, et al. Physical activity for the treatment of adolescent depression: a systematic review and meta-analysis. Front Physiol. 2020 Mar 19;11:185.Texto completo  Resumo

87. Kennard B, Silva S, Vitiello B, et al. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1404-11. Resumo

88. Emslie GJ, Kennard BD, Mayes TL, et al. Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth. J Child Adolesc Psychopharmacol. 2012 Feb;22(1):21-8.Texto completo  Resumo

89. Shamseddeen W, Clarke G, Keller MB, et al. Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study. J Child Adolesc Psychopharmacol. 2012 Feb;22(1):29-36.Texto completo  Resumo

90. Weisz JR, Kuppens S, Eckshtain D, et al. Performance of evidence-based youth psychotherapies compared with usual clinical care: a multilevel meta-analysis. JAMA Psychiatry. 2013 Jul;70(7):750-61.Texto completo  Resumo

91. Beardslee WR, Brent DA, Weersing VR, et al. Prevention of depression in at-risk adolescents: longer-term effects. JAMA Psychiatry. 2013 Nov;70(11):1161-70.Texto completo  Resumo

92. Weisz JR, Jensen-Doss A, Hawley KM. Evidence-based youth psychotherapies versus usual clinical care: a meta-analysis of direct comparisons. Am Psychol. 2006 Oct;61(7):671-89. Resumo

93. Goodyer IM, Dubicka B, Wilkinson P, et al. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors: the ADAPT trial. Health Technol Assess. 2008 May;12(14):iii-iv, ix-60. Resumo

94. Cox GR, Callahan P, Churchill R, et al. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents. Cochrane Database Syst Rev. 2014 Nov 30;2014(11):CD008324.Texto completo  Resumo

95. March JS, Silva S, Petrycki S, et al. The treatment for adolescents with depression study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007 Oct;64(10):1132-43.Texto completo  Resumo

96. Calati R, Pedrini L, Alighieri S, et al. Is cognitive behavioural therapy an effective complement to antidepressants in adolescents? A meta-analysis. Acta Neuropsychiatr. 2011 Dec;23(6):263-71. Resumo

97. Locher C, Koechlin H, Zion SR, et al. Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis. JAMA Psychiatry. 2017 Oct 1;74(10):1011-20.Texto completo  Resumo

98. Nemeroff CB, Kalali A, Keller MB, et al. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Arch Gen Psychiatry. 2007 Apr;64(4):466-72.Texto completo  Resumo

99. Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry. 1997 Nov;54(11):1031-7. Resumo

100. Emslie GJ, Heiligenstein JH, Wagner KD, et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry. 2002 Oct;41(10):1205-15. Resumo

101. March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004 Aug 18;292(7):807-20.Texto completo  Resumo

102. Hetrick SE, McKenzie JE, Cox GR, et al. Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst Rev. 2012 Nov 14;(11):CD004851.Texto completo  Resumo

103. Emslie GJ, Ventura D, Korotzer A, et al. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry. 2009 Jul;48(7):721-9. Resumo

104. Tao R, Emslie G, Mayes T, et al. Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder. J Am Acad Child Adolesc Psychiatry. 2009 Jan;48(1):71-8.Texto completo  Resumo

105. Heiligenstein JH, Hoog SL, Wagner KD, et al. Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study. J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):207-17. Resumo

106. Steinberg EM, Cardoso GM, Martinez PE, et al. Rapid response to fluoxetine in women with premenstrual dysphoric disorder. Depress Anxiety. 2012 Jun;29(6):531-40.Texto completo  Resumo

107. Gao SY, Wu QJ, Zhang TN, et al. Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies. Br J Clin Pharmacol. 2017 Oct;83(10):2134-47. Resumo

108. Wagner KD, Jonas J, Findling RL, et al. A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry. 2006 Mar;45(3):280-8. Resumo

109. Wagner KD, Ambrosini P, Rynn M, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA. 2003 Aug 27;290(8):1033-41.Texto completo  Resumo

110. Wagner KD, Robb AS, Findling RL, et al. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry. 2004 Jun;161(6):1079-83. Resumo

111. Berard R, Fong R, Carpenter DJ, et al. An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder. J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):59-75. Resumo

112. Emslie GJ, Wagner KD, Kutcher S, et al. Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):709-19. Resumo

113. Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):762-72. Resumo

114. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007 Apr 18;297(15):1683-96. Resumo

115. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006 Mar;63(3):332-9.Texto completo  Resumo

116. Greenhill LL, Vitiello B, Fisher P, et al. Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry. 2004 Dec;43(12):1488-96. Resumo

117. Vanderkooy JD, Kennedy SH, Bagby RM. Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine. Can J Psychiatry. 2002 Mar;47(2):174-80. Resumo

118. Day JC, Wood G, Dewey M, et al. A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. Br J Psychiatry. 1995 May;166(5):650-3. Resumo

119. Chehil S, Kutcher S. Mental health therapeutic outcomes tool (TOT). 2007 [internet publication].Texto completo

120. Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008 Feb 27;299(8):901-13.Texto completo  Resumo

121. Emslie GJ, Findling RL, Yeung PP, et al. Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials. J Am Acad Child Adolesc Psychiatry. 2007 Apr;46(4):479-88. Resumo

122. Mandoki MW, Tapia MR, Tapia MA, et al. Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacol Bull. 1997;33(1):149-54. Resumo

123. Cooper WO, Callahan ST, Shintani A, et al. Antidepressants and suicide attempts in children. Pediatrics. 2014 Feb;133(2):204-10.Texto completo  Resumo

124. Cheung AH, Emslie GJ, Mayes TL. Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatry. 2005 Jul;46(7):735-54.Texto completo  Resumo

125. Bschor T, Bauer M. Efficacy and mechanisms of action of lithium augmentation in refractory major depression. Curr Pharm Des. 2006;12(23):2985-92. Resumo

126. Carvalho AF, Cavalcante JL, Castelo MS, et al. Augmentation strategies for treatment-resistant depression: a literature review. J Clin Pharm Ther. 2007 Oct;32(5):415-28. Resumo

127. Abraham G, Milev R, Stuart Lawson J. T3 augmentation of SSRI resistant depression. J Affect Disord. 2006 Apr;91(2-3):211-5. Resumo

128. Aronson R, Offman HJ, Joffe RT, et al. Triiodothyronine augmentation in the treatment of refractory depression: a meta-analysis. Arch Gen Psychiatry. 1996 Sep;53(9):842-8. Resumo

129. Papakostas GI. Augmentation strategies in the treatment of major depressive disorder: examining the evidence on augmentation with atypical antipsychotics. CNS Spectr. 2007 Dec;12(12 suppl 22):10-2. Resumo

130. Komossa K, Depping AM, Gaudchau A, et al. Second-generation antipsychotics for major depressive disorder and dysthymia. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008121.Texto completo  Resumo

131. Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006 Mar 23;354(12):1243-52.Texto completo  Resumo

132. Kennard BD, Clarke GN, Weersing VR, et al. Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: preliminary findings. J Consult Clin Psychol. 2009 Dec;77(6):1033-41.Texto completo  Resumo

133. Carandang C, Robbins D, Mullany E, et al. Lamotrigine in adolescent mood disorders: a retrospective chart review. J Can Acad Child Adolesc Psychiatry. 2007 Feb;16(1):1-8.Texto completo  Resumo

134. Ryan ND, Meyer V, Dachille S, et al. Lithium antidepressant augmentation in TCA-refractory depression in adolescents. J Am Acad Child Adolesc Psychiatry. 1988 May;27(3):371-6. Resumo

135. Strober M, Freeman R, Rigali J, et al. The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine. J Am Acad Child Adolesc Psychiatry. 1992 Jan;31(1):16-20. Resumo

136. Papanikolaou K, Richardson C, Pehlivanidis A, et al. Efficacy of antidepressants in child and adolescent depression: a meta-analytic study. J Neural Transm (Vienna). 2006 Mar;113(3):399-415. Resumo

137. DelBello MP, Hochadel TJ, Portland B,et al. A double-blind, placebo-controlled study of selegiline transdermal system (EMSAM) in depressed adolescents. Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Toronto, Canada; October 18-23, 2011.

138. Swedo SE, Allen AJ, Glod CA, et al. A controlled trial of light therapy for the treatment of pediatric seasonal affective disorder. J Am Acad Child Adolesc Psychiatry. 1997 Jun;36(6):816-21. Resumo

139. Golden RN, Gaynes BN, Ekstrom RD, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005 Apr;162(4):656-62.Texto completo  Resumo

140. Rey JM, Walter G. Half a century of ECT use in young people. Am J Psychiatry. 1997 May;154(5):595-602. Resumo

141. Cala S, Crismon ML, Baumgartner J. A survey of herbal use in children with attention-deficit-hyperactivity disorder or depression. Pharmacotherapy. 2003 Feb;23(2):222-30. Resumo

142. Fegert JM, Kolch M, Zito JM, et al. Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):197-206. Resumo

143. Linde K, Mulrow CD, Berner M, et al. St John's wort for major depression. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD000448.Texto completo  Resumo

144. Mischoulon D. Update and critique of natural remedies as antidepressant treatments. Psychiatr Clin North Am. 2007 Mar;30(1):51-68. Resumo

145. Findling RL, McNamara NK, O'Riordan MA, et al. An open-label pilot study of St. John's wort in juvenile depression. J Am Acad Child Adolesc Psychiatry. 2003 Aug;42(8):908-14. Resumo

146. Hübner WD, Kirste T. Experience with St John's wort (Hypericum perforatum) in children under 12 years with symptoms of depression and psychovegetative disturbances. Phytother Res. 2001 Jun;15(4):367-70. Resumo

147. Simeon J, Nixon MK, Milin R, et al. Open-label pilot study of St. John's wort in adolescent depression. J Child Adolesc Psychopharmacol. 2005 Apr;15(2):293-301. Resumo

148. Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007 Jul;68(7):1056-61. Resumo

149. Nemets H, Nemets B, Apter A, et al. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry. 2006 Jun;163(6):1098-100. Resumo

150. Papakostas GI, Alpert JE, Fava M. S-adenosyl-methionine in depression: a comprehensive review of the literature. Curr Psychiatry Rep. 2003 Dec;5(6):460-6. Resumo

151. Alpert JE, Papakostas G, Mischoulon D, et al. S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine.J Clin Psychopharmacol. 2004 Dec;24(6):661-4. Resumo

152. Schaller JL, Thomas J, Bazzan AJ. SAMe use in children and adolescents. Eur Child Adolesc Psychiatry. 2004 Oct;13(5):332-4. Resumo

153. Bloch Y, Grisaru N, Harel EV, et al. Repetitive transcranial magnetic stimulation in the treatment of depression in adolescents: an open-label study. J ECT. 2008 Jun;24(2):156-9. Resumo

154. D'Agati D, Bloch Y, Levkovitz Y, et al. rTMS for adolescents: safety and efficacy considerations. Psychiatry Res. 2010 May 30;177(3):280-5. Resumo

155. Marangell LB, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry. 2002 Feb 15;51(4):280-7. Resumo

156. Rush AJ, George MS, Sackeim HA, et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry. 2000 Feb 15;47(4):276-86. Resumo

157. Sackeim HA, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 2001 Nov;25(5):713-28.Texto completo  Resumo

158. Sanacora G, Zarate CA Jr, Krystal JH, et al. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov. 2008 May;7(5):426-37.Texto completo  Resumo

159. Zarate CA Jr, Singh JB, Quiroz JA, et al. A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am J Psychiatry. 2006 Jan;163(1):153-5. Resumo

160. Newport DJ, Carpenter LL, McDonald WM, et al. Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression. Am J Psychiatry. 2015 Oct;172(10):950-66. Resumo

161. Short B, Fong J, Galvez V, et al. Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry. 2018 Jan;5(1):65-78. Resumo

162. Zajecka J, Schatzberg A, Stahl S, et al. Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2010 Apr;30(2):135-44. Resumo

163. Hale A, Corral RM, Mencacci C, et al. Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study. Int Clin Psychopharmacol. 2010 Nov;25(6):305-14. Resumo

164. Kasper S, Hajak G, Wulff K, et al. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. J Clin Psychiatry. 2010 Feb;71(2):109-20. Resumo

165. Goodwin GM, Emsley R, Rembry S, et al. Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2009 Aug;70(8):1128-37. Resumo

166. Archer G, Kuh D, Hotopf M, et al. Adolescent affective symptoms and mortality. Br J Psychiatry. 2018 Jul;213(1):419-24.Texto completo  Resumo

167. Conwell Y, Duberstein PR, Cox C, et al. Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. Am J Psychiatry. 1996 Aug;153(8):1001-8. Resumo

168. Stanley B, Brown GK, Brenner LA, et al. Comparison of the safety planning intervention with follow-up vs usual care of suicidal patients treated in the emergency department. JAMA Psychiatry. 2018 Sep 1;75(9):894-900.Texto completo  Resumo

169. Morrato EH, Libby AM, Orton HD, et al. Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry. 2008 Jan;165(1):42-50. Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal